Year-long dataset evaluating percutaneous disc augmentation technology shows the HYDRAFIL System improved back and leg pain and disability scores exceeding clinical significance benchmarks at ...
Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, today ...
Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced the completion of the ...
AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a medical device company redefining soft-tissue protection in orthopedic surgery, announced today the first clinical use of its ...
BEDFORD, Mass.--(BUSINESS WIRE)-- Augmenix, Inc. is pleased to announce that the company’s leading product, SpaceOAR hydrogel, is now available to millions of American men covered under Medicare, ...
Hydrogels have a variety of use cases, including contact lenses, delivering doses of medication within the body, moisturisers, water storage in soil, cleaning polluted water and as gelling and ...
Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...
AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a medical device company redefining soft-tissue protection in orthopedic surgery, announced today the first clinical use of its ...